These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26952654)

  • 1. An activated factor VII variant with enhanced tissue factor-independent activity speeds wound healing in a mouse hemophilia B model.
    Hoffman M; Chang JY; Ezban M; Monroe DM
    J Thromb Haemost; 2016 Jun; 14(6):1249-54. PubMed ID: 26952654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B.
    McDonald A; Hoffman M; Hedner U; Roberts HR; Monroe DM
    J Thromb Haemost; 2007 Aug; 5(8):1577-83. PubMed ID: 17663728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.
    Keshava S; Sundaram J; Rajulapati A; Pendurthi UR; Rao LV
    J Thromb Haemost; 2016 Mar; 14(3):546-50. PubMed ID: 26727350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound healing in hemophilia B mice and low tissue factor mice.
    Monroe DM; Mackman N; Hoffman M
    Thromb Res; 2010 Apr; 125 Suppl 1(Suppl 1):S74-7. PubMed ID: 20170942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive improvement in wound healing with increased therapy in haemophilia B mice.
    Monroe DM; Hoffman M; Roberts HR; Hedner U
    Haemophilia; 2013 Nov; 19(6):926-32. PubMed ID: 23879625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity.
    Fager AM; Machlus KR; Ezban M; Hoffman M
    J Thromb Haemost; 2018 Sep; 16(9):1817-1829. PubMed ID: 29879294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FVIIa as used pharmacologically is not TF dependent in hemophilia B mice.
    Feng D; Whinna H; Monroe D; Stafford DW
    Blood; 2014 Mar; 123(11):1764-6. PubMed ID: 24425804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis.
    Sun J; Hua B; Livingston EW; Taves S; Johansen PB; Hoffman M; Ezban M; Monroe DM; Bateman TA; Monahan PE
    Blood; 2017 Apr; 129(15):2161-2171. PubMed ID: 28039188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.
    Gruppo RA; Malan D; Kapocsi J; Nemes L; Hay CRM; Boggio L; Chowdary P; Tagariello G; von Drygalski A; Hua F; Scaramozza M; Arkin S;
    J Thromb Haemost; 2018 Oct; 16(10):1984-1993. PubMed ID: 30151972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A.
    Tranholm M; Kristensen K; Kristensen AT; Pyke C; Røjkjaer R; Persson E
    Blood; 2003 Nov; 102(10):3615-20. PubMed ID: 12869500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo.
    Margaritis P; Roy E; Faella A; Downey HD; Ivanciu L; Pavani G; Zhou S; Bunte RM; High KA
    Blood; 2011 Apr; 117(15):3974-82. PubMed ID: 21325603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent.
    Hedner U; Brun NC
    Neuroradiology; 2007 Oct; 49(10):789-93. PubMed ID: 17653706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms.
    Ogiwara K; Nogami K; Shima M
    Thromb Haemost; 2011 Oct; 106(4):665-74. PubMed ID: 21901232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low intensity laser therapy speeds wound healing in hemophilia by enhancing platelet procoagulant activity.
    Hoffman M; Monroe DM
    Wound Repair Regen; 2012; 20(5):770-7. PubMed ID: 22882528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose factor VIIa improves clot structure and stability in a model of haemophilia B.
    Wolberg AS; Allen GA; Monroe DM; Hedner U; Roberts HR; Hoffman M
    Br J Haematol; 2005 Dec; 131(5):645-55. PubMed ID: 16351642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophilia.
    McDonald AG; Yang K; Roberts HR; Monroe DM; Hoffman M
    Blood; 2008 Feb; 111(4):2046-8. PubMed ID: 18055866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa.
    Lindley CM; Sawyer WT; Macik BG; Lusher J; Harrison JF; Baird-Cox K; Birch K; Glazer S; Roberts HR
    Clin Pharmacol Ther; 1994 Jun; 55(6):638-48. PubMed ID: 8004880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
    Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
    Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.